

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational p...
Q2 2026
Aug 5, 2026
Q1 2026
May 6, 2026
FY 2025
Feb 24, 2026
Q4 2025
Feb 24, 2026
Q3 2025
Nov 4, 2025